These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 19248780)
1. The Apc 1322T mouse develops severe polyposis associated with submaximal nuclear beta-catenin expression. Pollard P; Deheragoda M; Segditsas S; Lewis A; Rowan A; Howarth K; Willis L; Nye E; McCart A; Mandir N; Silver A; Goodlad R; Stamp G; Cockman M; East P; Spencer-Dene B; Poulsom R; Wright N; Tomlinson I Gastroenterology; 2009 Jun; 136(7):2204-2213.e1-13. PubMed ID: 19248780 [TBL] [Abstract][Full Text] [Related]
2. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180 [TBL] [Abstract][Full Text] [Related]
3. Refining the relation between 'first hits' and 'second hits' at the APC locus: the 'loose fit' model and evidence for differences in somatic mutation spectra among patients. Crabtree M; Sieber OM; Lipton L; Hodgson SV; Lamlum H; Thomas HJ; Neale K; Phillips RK; Heinimann K; Tomlinson IP Oncogene; 2003 Jul; 22(27):4257-65. PubMed ID: 12833148 [TBL] [Abstract][Full Text] [Related]
4. Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) mice. Musteanu M; Blaas L; Mair M; Schlederer M; Bilban M; Tauber S; Esterbauer H; Mueller M; Casanova E; Kenner L; Poli V; Eferl R Gastroenterology; 2010 Mar; 138(3):1003-11.e1-5. PubMed ID: 19962983 [TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer and genetic alterations in the Wnt pathway. Segditsas S; Tomlinson I Oncogene; 2006 Dec; 25(57):7531-7. PubMed ID: 17143297 [TBL] [Abstract][Full Text] [Related]
6. Beta-catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours. Kohler EM; Chandra SH; Behrens J; Schneikert J Hum Mol Genet; 2009 Jan; 18(2):213-26. PubMed ID: 18854359 [TBL] [Abstract][Full Text] [Related]
7. Contribution of the 15 amino acid repeats of truncated APC to beta-catenin degradation and selection of APC mutations in colorectal tumours from FAP patients. Kohler EM; Brauburger K; Behrens J; Schneikert J Oncogene; 2010 Mar; 29(11):1663-71. PubMed ID: 19966865 [TBL] [Abstract][Full Text] [Related]
8. Wnt pathway mutations selected by optimal beta-catenin signaling for tumorigenesis. Cho KH; Baek S; Sung MH FEBS Lett; 2006 Jun; 580(15):3665-70. PubMed ID: 16764864 [TBL] [Abstract][Full Text] [Related]
9. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis. Li Q; Ishikawa TO; Oshima M; Taketo MM Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028 [TBL] [Abstract][Full Text] [Related]
10. Apc mice: models, modifiers and mutants. McCart AE; Vickaryous NK; Silver A Pathol Res Pract; 2008; 204(7):479-90. PubMed ID: 18538487 [TBL] [Abstract][Full Text] [Related]
11. Colorectal cancers show distinct mutation spectra in members of the canonical WNT signaling pathway according to their anatomical location and type of genetic instability. Albuquerque C; Baltazar C; Filipe B; Penha F; Pereira T; Smits R; Cravo M; Lage P; Fidalgo P; Claro I; Rodrigues P; Veiga I; Ramos JS; Fonseca I; Leitão CN; Fodde R Genes Chromosomes Cancer; 2010 Aug; 49(8):746-59. PubMed ID: 20544848 [TBL] [Abstract][Full Text] [Related]
12. [From gene to disease; the APC gene and familial adenomatous polyposis coli]. van der Luijt RB; Tops CM; Vasen HF Ned Tijdschr Geneeskd; 2000 Oct; 144(42):2007-9. PubMed ID: 11072519 [TBL] [Abstract][Full Text] [Related]
13. A genetic study of the role of the Wnt/beta-catenin signalling in Paneth cell differentiation. Andreu P; Peignon G; Slomianny C; Taketo MM; Colnot S; Robine S; Lamarque D; Laurent-Puig P; Perret C; Romagnolo B Dev Biol; 2008 Dec; 324(2):288-96. PubMed ID: 18948094 [TBL] [Abstract][Full Text] [Related]
14. Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling. Kielman MF; Rindapää M; Gaspar C; van Poppel N; Breukel C; van Leeuwen S; Taketo MM; Roberts S; Smits R; Fodde R Nat Genet; 2002 Dec; 32(4):594-605. PubMed ID: 12426568 [TBL] [Abstract][Full Text] [Related]
15. The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade. Albuquerque C; Breukel C; van der Luijt R; Fidalgo P; Lage P; Slors FJ; Leitão CN; Fodde R; Smits R Hum Mol Genet; 2002 Jun; 11(13):1549-60. PubMed ID: 12045208 [TBL] [Abstract][Full Text] [Related]
16. Elevated Dnmt3a activity promotes polyposis in Apc(Min) mice by relaxing extracellular restraints on Wnt signaling. Samuel MS; Suzuki H; Buchert M; Putoczki TL; Tebbutt NC; Lundgren-May T; Christou A; Inglese M; Toyota M; Heath JK; Ward RL; Waring PM; Ernst M Gastroenterology; 2009 Sep; 137(3):902-13, 913.e1-11. PubMed ID: 19454286 [TBL] [Abstract][Full Text] [Related]
17. Subcellular localization of beta-catenin and APC proteins in colorectal preneoplastic and neoplastic lesions. Sena P; Saviano M; Monni S; Losi L; Roncucci L; Marzona L; De Pol A Cancer Lett; 2006 Sep; 241(2):203-12. PubMed ID: 16298038 [TBL] [Abstract][Full Text] [Related]
18. Development of gastric tumors in Apc(Min/+) mice by the activation of the beta-catenin/Tcf signaling pathway. Tomita H; Yamada Y; Oyama T; Hata K; Hirose Y; Hara A; Kunisada T; Sugiyama Y; Adachi Y; Linhart H; Mori H Cancer Res; 2007 May; 67(9):4079-87. PubMed ID: 17483318 [TBL] [Abstract][Full Text] [Related]
19. Germline APC mutation on the beta-catenin binding site is associated with a decreased apoptotic level in colorectal adenomas. Venesio T; Balsamo A; Scordamaglia A; Bertolaso M; Arrigoni A; Sprujevnik T; Rossini FP; Risio M Mod Pathol; 2003 Jan; 16(1):57-65. PubMed ID: 12527714 [TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers. Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]